Table 4.

Adjusted results for the main outcomes including the imbalance baseline variables. Generalized lineal model.

Parameter	RR	Wald 95%CI for RR		p-value
Adherence 90 days
MEntA group	4.57	1.67	12.51	<0.001
Control group	1 (reference category)
No studies	1.87	0.26	13.33	0.53
Primary studies	1.92	0.58	6.39	0.29
Secondary studies	0.66	0.17	2.47	0.53
University studies	1 (reference category)
ESS	0.98	0.88	1.09	0.69
Cepca total
MEntA group	127.03	46.11	349.94	<0.001
Control group	1 (reference category)
No studies	0.51	0.07	3.88	0.52
Primary studies	0.31	0.09	1.05	0.06
Secondary studies	0.54	0.14	2.07	0.37
University studies	1 (reference category)
ESS	0.96	0.86	1.07	0.50
Quality of Life
MEntA group	5.86	2.36	14.56	<0.001
Control group	1 (reference category)
No studies	0.90	0.15	5.29	0.91
Primary studies	0.56	0.19	1.67	0.30
Secondary studies	0.69	0.21	2.30	0.55
University studies	1 (reference category)
ESS	0.97	0.88	1.07	0.60

RR: relative risk. ESS: Epworth Sleepiness Scale. CEPCA: Questionnaire of Evaluation of Perceived Competence in Adherence to CPAP in OSA. QoL: Visual Analogical Well-being Scale for apnoea.